Correlation Between Universe Pharmaceuticals and Vor Biopharma
Can any of the company-specific risk be diversified away by investing in both Universe Pharmaceuticals and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Universe Pharmaceuticals and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Universe Pharmaceuticals and Vor Biopharma, you can compare the effects of market volatilities on Universe Pharmaceuticals and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Universe Pharmaceuticals with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Universe Pharmaceuticals and Vor Biopharma.
Diversification Opportunities for Universe Pharmaceuticals and Vor Biopharma
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Universe and Vor is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Universe Pharmaceuticals and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Universe Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Universe Pharmaceuticals are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Universe Pharmaceuticals i.e., Universe Pharmaceuticals and Vor Biopharma go up and down completely randomly.
Pair Corralation between Universe Pharmaceuticals and Vor Biopharma
Considering the 90-day investment horizon Universe Pharmaceuticals is expected to under-perform the Vor Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Universe Pharmaceuticals is 2.61 times less risky than Vor Biopharma. The stock trades about -0.17 of its potential returns per unit of risk. The Vor Biopharma is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 87.00 in Vor Biopharma on October 24, 2024 and sell it today you would earn a total of 49.00 from holding Vor Biopharma or generate 56.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Universe Pharmaceuticals vs. Vor Biopharma
Performance |
Timeline |
Universe Pharmaceuticals |
Vor Biopharma |
Universe Pharmaceuticals and Vor Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Universe Pharmaceuticals and Vor Biopharma
The main advantage of trading using opposite Universe Pharmaceuticals and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Universe Pharmaceuticals position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.The idea behind Universe Pharmaceuticals and Vor Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Vor Biopharma vs. Monte Rosa Therapeutics | Vor Biopharma vs. Design Therapeutics | Vor Biopharma vs. Erasca Inc | Vor Biopharma vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |